Human Technology Q1 Performance Deteriorates: Revenue Plunges, Operating Loss Widens
-
Q1 consolidated revenue KRW 9.16bn (down 27.8% YoY), operating loss KRW 2.96bn (vs loss KRW 1.99bn YoY), net loss KRW 3.75bn (vs loss KRW 1.69bn YoY)
-
Continued losses: retained deficit -KRW 84.1bn, debt ratio 42.54% (improved from 50.13% at year-end but accumulated deficit deepens)
-
EPS loss -KRW 150 (vs -KRW 76 YoY); trade receivables allowance rate 50.15%; royalty provision KRW 1.03bn
-
High customer concentration: Top customer A accounted for 58% of sales; credit rating maintained at B- (Ecredible)
-
Disposal of subsidiary CarboX shares; planned merger with Humans Agos (June 30, 2026) — restructuring with unclear short-term improvement
-
No share buyback, cancellation, or dividend announcements
KOSDAQ Filing Information
-
Filing: Quarterly Report (2026.03)
-
Company: Human Technology (175140)
-
Submission: Human Technology Co., Ltd
-
Receipt: 05-15-2026